Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinlian Qingre Effervescent Tablets for pediatric hand-foot-and-mouth disease
ChiCTR-TRC-12002355Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Feb 2012
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jinlian Qingre in hand, foot, and mouth disease (HFMD) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Time of body temperature going back to normal. Started Feb 2012; status: completed.
02
Drugs
Jinlian Qingre
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on ChiCTR-TRC-12002355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002355.